GOVINDAN SERENGULAM V

Overview

About

GOVINDAN SERENGULAM V has a total of 15 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SEATTLE GENETICS INC, TAP PHARMACEUTICALS INC and JANSSEN ALZHEIMER IMMUNOTHERAP.

Patent filings in countries

#	Country	Total Patents
#1	United States	13
#2	WIPO (World Intellectual Property Organization)	2

#	Industry
#1	Pharmaceuticals
#2	Biotechnology
#3	Environmental technology
#4	Macromolecular chemistry and polymers
#5	Micro-structure and nano-technology
#6	Measurement
#7	Medical technology
#8	Organic fine chemistry

#	Technology
#1	Medical preparations
#2	Peptides
#3	Therapeutic chemical compounds
#4	Climate change adaptation technologies
#5	Nanostructure applications
#6	Heterocyclic compounds
#7	Analysing materials
#8	Special macromolecular compounds
#9	Polysaccharides
#10	Electrotherapy

Publication	Filing date	Title
US2011305631A1	2011-08-19	Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
US2011070156A1	2010-12-01	Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
US2010233779A1	2010-04-23	Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
US2006193865A1	2006-03-23	Camptothecin-binding moiety conjugates